4//SEC Filing
Asterias Biotherapeutics, Inc. 4
Accession 0001140361-17-001564
CIK 0001572552operating
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 4:30 PM ET
Size
5.9 KB
Accession
0001140361-17-001564
Insider Transaction Report
Form 4
Wirth Edward
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2017-01-09−2,056→ 3,415 total - Sale
Common Stock
2017-01-09$4.60/sh−3,415$15,719→ 0 total
Footnotes (2)
- [F1]Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 5,471 Restricted Stock Units, the grant of which was previously reported on a Form 4.
- [F2]The shares sold were sold pursuant to a Rule 10b5-1 Plan adopted by the reporting person.
Documents
Issuer
Asterias Biotherapeutics, Inc.
CIK 0001572552
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001572552
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 4:30 PM ET
- Size
- 5.9 KB